Showing 421 - 440 results of 457 for search '"patents"', query time: 0.05s Refine Results
  1. 421

    Resistance of Biomphalaria alexandrina to Schistosoma mansoni and Bulinus truncatus to Schistosoma haematobium Correlates with Unsaturated Fatty Acid Levels in the Snail Soft Tissu... by Marian Elias, Rasha S. Hanafi, Samia El-Bardicy, Ebtisam A. Hafez, Rashika El Ridi

    Published 2020-01-01
    “…Only a fraction of the Biomphalaria and Bulinus snail community shows patent infection with schistosomes despite continuous exposure to the parasite, indicating that a substantial proportion of snails may resist infection. …”
    Get full text
    Article
  2. 422

    A Comparative Analysis of the Performance of Leading Countries in Conducting Artificial Intelligence Research by Ahmed H. Al-Marzouqi, Alya A. Arabi

    Published 2024-01-01
    “…These three countries (along with the United States) also had the highest economic impact as measured by the patent citations per scholarly output, which was aligned with the high FWCI values for these countries. …”
    Get full text
    Article
  3. 423

    Clinical value of quantitative echocardiographic features in preterm infants with necrotizing enterocolitis by Wenmei li, Wenqiang Sun, Zexi Sun, Huawei Wang, Xueping Zhu

    Published 2025-01-01
    “…Umbilical vein cannulation, antibiotic duration, total red blood cell infusion, duration of total parenteral and total enteral nutrition, respiratory failure, hemodynamically significant patent ductus arteriosus, anemia, neutropenia, hyperbilirubinemia were significantly higher than those in the control group. …”
    Get full text
    Article
  4. 424

    Peripheral Artery Disease Intervention: Drug-Coated Balloon vs Drug-Eluting Stent, A Long-Term Comparison by Nathan Marzlin, M. Fuad Jan, Louie Kostopoulos, Ana Cristina Perez Moreno, Tanvir Bajwa, Suhail Q. Allaqaband

    Published 2022-01-01
    “…For patients requiring TLR, DES remained patent significantly longer (373 days longer on average) (p < 0.001). …”
    Get full text
    Article
  5. 425

    Restructuring of Global Pharmaceutical Supply Chains after COVID-19 by N. A. Volgina

    Published 2022-03-01
    “…The paper proposes one of the possible classifications of pharmaceutical chains depending on the technologies used, where the following are distinguished: low-tech and medium-low-tech chains (production of essential pharmaceutical goods); medium-high-tech chains (production of generics); high-tech chains (production of patented drugs, production of biopharmaceuticals, production of medical equipment). …”
    Get full text
    Article
  6. 426

    Exploring the Therapeutic Landscape: A Narrative Review on Topical and Oral Phosphodiesterase-4 Inhibitors in Dermatology by Elena Carmona-Rocha, Lluís Rusiñol, Lluís Puig

    Published 2025-01-01
    “…Roflumilast is a PDE4 inhibitor that was approved by the FDA and the EMA as an oral treatment of chronic obstructive pulmonary disease. Since patent expiration, several generic formulations of oral roflumilast have become available, and various studies have documented its off-label use in psoriasis and other dermatological conditions such as hidradenitis suppurativa, recurrent oral aphthosis, nummular eczema, lichen planus, and Behçet’s disease. …”
    Get full text
    Article
  7. 427

    Chinese medicine for headaches in emergency department: a retrospective analysis of real-world electronic medical records by Zhenhui Mao, Shirong Wu, Yuzhen Fan, Jingbo Sun, Shaohua Lyu, Qiaozhen Su

    Published 2025-01-01
    “…Conversely, over one-third of the patients utilized headache-specific patented Chinese herbal medicine products. Additionally, oral and topical Chinese herbal medicine treatments were also administered for headaches in the emergency departments.ConclusionThe majority of headaches consulting in the EDs were non-urgent and treated with various forms of Chinese medicine, alone or in conjunction of western medicine. …”
    Get full text
    Article
  8. 428

    MOMAST<sup>®</sup> Downregulates AQP3 Expression and Function in Human Colon Cells by Ines Angelini, Mariangela Centrone, Giusy Rita Caponio, Annarita Di Mise, Andrea Gerbino, Marianna Ranieri, Giovanna Valenti, Grazia Tamma

    Published 2024-12-01
    “…MOMAST<sup>®</sup> is an antioxidant-patented natural phenolic complex obtained from olive wastewater (OWW) of the Coratina cultivar. …”
    Get full text
    Article
  9. 429

    Crop protection by RNA interference: a review of recent approaches, current state of developments and use as of 2013 by Kirsten Germing, Cecilia Andrea Díaz Navarrete, Andreas Schiermeyer, Udo Hommen, Luise Zühl, Sebastian Eilebrecht, Elke Eilebrecht

    Published 2025-01-01
    “…Furthermore, we identified 268 patent families on this topic. A large variety with regard to treated crops, targeted pest species and target gene functions as well as application types was observed. …”
    Get full text
    Article
  10. 430

    Acute Occlusion of the Infarct-Related Artery as a Predictor of Very Long-Term Mortality in Patients with Acute Myocardial Infarction by Nikola Kos, Ivan Zeljković, Tomislav Krčmar, Karlo Golubić, Fran Šaler, Marijan Erceg, Diana Delić-Brkljačić, Nikola Bulj

    Published 2021-01-01
    “…Patients with angiographically proven IRA occlusion (100% stenosis with TIMI flow 0 distal to occlusion) were categorized as occlusive myocardial infarction (OMI) and patients with patent IRA (50–99% stenosis with TIMI 1–3 flow) were categorized as nonocclusive myocardial infarction (NOMI) and very long-term outcomes were analyzed. …”
    Get full text
    Article
  11. 431

    Echocardiographic Findings in Patients with Atrial Septal Aneurysm: A Prospective Case-Control Study by Ramazan Atak, Mehmet Ileri, Selcuk Ozturk, Ahmet Korkmaz, Ertan Yetkin

    Published 2019-01-01
    “…Aortic valve regurgitation and mitral valve regurgitation were more often observed in patients with ASA, and percentages of patients with ascending aortic aneurysm (AAA), patent foramen ovale (PFO), and atrial septal defect (ASD) were higher in ASA patients compared to control group patients. …”
    Get full text
    Article
  12. 432

    Microtransesophageal Echocardiographic Guidance during Percutaneous Interatrial Septal Closure without General Anaesthesia by Roel J. R. Snijder, Laura E. Renes, Martin J. Swaans, Maarten Jan Suttorp, Jurrien M. Ten Berg, Martijn C. Post

    Published 2020-01-01
    “…To study the safety and efficacy of microtransesophageal echocardiography (micro-TEE) and TEE during percutaneous atrial septal defect (ASD) and patent foramen ovale (PFO) closure. Background. TEE has proven to be safe during ASD and PFO closure under general anaesthesia. …”
    Get full text
    Article
  13. 433

    Assessment of the effect of hemostatic materials on blood calcium concentration by V. A. Lipatov, S. V. Lazarenko, D. A. Severinov

    Published 2021-06-01
    “…Evaluation of the effect of hemostatic materials on blood calcium concentration was carried out according to the described method: «Method for comparative investigation of the effectiveness of local hemostatic agents in an in vitro experiment» Russian patent No. 2709 517. According to the results of the study, median, 25 and 75 percentiles were calculated. …”
    Get full text
    Article
  14. 434

    Home management of malaria among caregivers of under-five children in Owo, Ondo State, Nigeria by Liasu Adeagbo Ahmed, Olubankole Akinboboye, Olayinka Stephen Ilesanmi, David Akintayo Oguntuase

    Published 2017-11-01
    “…Most of the caregivers bought antifever drugs from patent medicine shops and only 11.9 % of them got a prescription drug from pharmacies. …”
    Get full text
    Article
  15. 435
  16. 436

    A Cost-Effective and Robust Cell-Based Bioassay Method for Evaluating the Bioactivity of Trastuzumab-like Antibodies by Pooja Bharali, Subhash Chand, Harish Chander

    Published 2024-12-01
    “…The cost-effectiveness, global demand, and patent expiration of trastuzumab have led to the inflow of its biosimilars in the global market. …”
    Get full text
    Article
  17. 437

    A Decades-Long Journey of Palmitoylethanolamide (PEA) for Chronic Neuropathic Pain Management: A Comprehensive Narrative Review by Giustino Varrassi, Martina Rekatsina, Matteo Luigi Giuseppe Leoni, Marco Cascella, Gabriele Finco, Salvatore Sardo, Chiara Corno, Domenico Tiso, Vittorio Schweiger, Diego Maria Michele Fornasari, Antonella Paladini

    Published 2024-12-01
    “…Finally, it examines some innovative patent, which aims to address obstacles encountered with conventional PEA formulations, for its pharmacodynamic characteristics. …”
    Get full text
    Article
  18. 438

    Abnormal characteristics of inferior vena cava and abdominal aorta among neonates with early onset septic shock by Lanlan Mi, Yiman Liu, Fei Bei, Jianhua Sun, Jun Bu, Yuqi Zhang, Weiwei Guo

    Published 2025-01-01
    “…Methods A total of 200 normal newborns were enrolled as controls and subdivided into groups based on GA, BW, days of age, and patent ductus arteriosus (PDA). Echocardiography was used to document inferior vena cava diameter (IVC), inferior vena cava collapsibility index (IVC-CI), and inferior vena cava to abdominal aorta ratio (IVC/AO). …”
    Get full text
    Article
  19. 439

    Stent-graft implantation for late postpancreatectomy hemorrhage after pancreatoduodenectomy by Xiaoye Li, Shibo Xia, Liangxi Yuan, Lei Zhang, Chao Song, Xiaolong Wei, Qingsheng Lu

    Published 2025-01-01
    “…All pseudoaneurysm or contrast extravasation sites were successfully excluded with patent distal perfusion, thus technical success was achieved in all cases. …”
    Get full text
    Article
  20. 440

    A Decontamination Process to Remove Metals and Stabilise Montreal Sewage Sludge by G. Mercier, J.F. Blais, F. Hammy, M. Lounes, J.L. Sasseville

    Published 2002-01-01
    “…To solve this particular problem, the treatment plant authorities are currently evaluating an acidic chemical leaching (sulfuric or hydrochloric acid) process at a pH between 2 and 3, using an oxidizing agent such as ferric chloride or hydrogen peroxide (METIX-AC technology, patent pending; [20]). They could integrate it to a 70 tds/day granulated sludge production process. …”
    Get full text
    Article